Despite Unanimously Passing Senate, Rhode Island Fails to Pass Contract Pharmacy Protection Bill 

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
A state Senate-endorsed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the legislature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Sues HHS, HRSA for Contract Details Between Covered Entities, Pharmacies

Drug manufacturer Sanofi has sued the federal government for information about contracts between covered entities and contract pharmacies.
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law

Attorneys representing the drug industry, the state of Louisiana, and Louisiana health centers presented oral arguments before a federal district court.
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Fully Exempts West Virginia Providers From 340B Contract Pharmacy Restrictions

Drug manufacturer Merck announced it will end its 340B contract pharmacy restrictions in West Virginia.
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bausch & Lomb Becomes 35th Manufacturer to Impose Contract Pharmacy Restrictions, Policy Applies to All 340B Entities

Canadian drug manufacturer Bausch & Lomb announced contract pharmacy restrictions that apply to all 340B covered entity types.
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Alkermes Is 36th Drugmaker to Implement Contract Pharmacy Restrictions, Sanofi Tightens Policy

Pharmaceutical manufacturer Alkermes is the 36th drugmaker to implement 340B contract pharmacy restrictions.
Irish drugmaker Alkermes will implement, on July 22, 340B contract pharmacy restrictions. The Dublin-based manufacturer is the 36th drugmaker to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Michigan Lawmakers, Witnesses Spar Over 340B Contract Pharmacy Access Bill in Key Hearing

Ben Frederick, associate vice president of advocacy and government relations at Memorial Healthcare, testified in support of a 340B contract pharmacy access bill at a Michigan state house hearing.
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Manufacturers Announce Refunds to 340B Providers

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live